Viewing Study NCT04925193


Ignite Creation Date: 2025-12-25 @ 1:21 AM
Ignite Modification Date: 2026-02-20 @ 10:10 PM
Study NCT ID: NCT04925193
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-24
First Post: 2021-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Personalized Selinexor-based Therapy for Relapsed/Refractory Multiple Myeloma
Sponsor: University of Colorado, Denver
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module